This report contains market size and forecasts of Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) in Global, including the following market information:
Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) include Pfizer Inc., Alexion Pharmaceuticals Inc., BioMarin Pharmaceutical Inc., Ultragenyx Pharmaceutical Inc., Janssen Pharmaceuticals Inc., Sigma-Tau Pharmaceuticals Inc., AbbVie Inc., Sanofi SA and Shire PLC and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Segment Percentages, by Type, 2021 (%)
Oral
Parenteral
Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc.
Alexion Pharmaceuticals Inc.
BioMarin Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Janssen Pharmaceuticals Inc.
Sigma-Tau Pharmaceuticals Inc.
AbbVie Inc.
Sanofi SA
Shire PLC
Merck KGaA